- Company Overview for OXVAX LIMITED (13201210)
- Filing history for OXVAX LIMITED (13201210)
- People for OXVAX LIMITED (13201210)
- Insolvency for OXVAX LIMITED (13201210)
- More for OXVAX LIMITED (13201210)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
14 Apr 2021 | AP01 | Appointment of Dr Thomas Hanke as a director on 7 April 2021 | |
14 Apr 2021 | AP01 | Appointment of Mr Marcelo Leonardo Bravo Cordero as a director on 7 April 2021 | |
07 Apr 2021 | PSC02 | Notification of The Chancellor, Masters and Scholars of the University of Oxford as a person with significant control on 1 April 2021 | |
06 Apr 2021 | PSC07 | Cessation of Paul Fairchild as a person with significant control on 1 April 2021 | |
06 Apr 2021 | PSC07 | Cessation of Marcelo Bravo as a person with significant control on 1 April 2021 | |
06 Apr 2021 | PSC07 | Cessation of Timothy Davies as a person with significant control on 1 April 2021 | |
06 Apr 2021 | SH01 |
Statement of capital following an allotment of shares on 1 April 2021
|
|
26 Feb 2021 | PSC01 | Notification of Marcelo Bravo as a person with significant control on 25 February 2021 | |
26 Feb 2021 | PSC01 | Notification of Timothy Davies as a person with significant control on 25 February 2021 | |
26 Feb 2021 | PSC04 | Change of details for Professor Paul Fairchild as a person with significant control on 25 February 2021 | |
26 Feb 2021 | SH01 |
Statement of capital following an allotment of shares on 25 February 2021
|
|
15 Feb 2021 | NEWINC |
Incorporation
Statement of capital on 2021-02-15
|